Your Cart Is Empty!
The world in vitro diagnostics market is estimated to garner $81.3 billion by 2022, registering a CAGR of 4.9% over the forecast period. Growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalised medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In addition, increasing incidences of colorectal cancer, neurological disorders, gynaecological diseases and others would boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market. The rising demand for technologically advanced diagnostic devices and increased disposable income of consumers provides huge growth potential for IVD market.
The report segments the market across different categories such as product type, techniques, application, end users and geography. Based on product types, the market is segmented into reagents, instruments, and services & software. Based on techniques, the market is segmented into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other clinical techniques. Similarly, based on indication, the market is further segmented into, infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal disorders and other indications. Based on end users, the market is categorised into standalone laboratory, hospitals academics & medical schools and others. The geographical breakdown and detailed analysis of each of the aforesaid segments are included for North America, Europe, Asia-Pacific and LAMEA.
Companies are adopting acquisition and partnership as key development strategies in this market Roche diagnostics, Abbott, Danaher Corporation are few of the dominant players in the IVD market. Other companies include Johnson and Johnson, Sysmex Corporation, Becton Dickinson, bioMrieux, Thermo Fisher Scientific, Inc., Ortho-Clinical Diagnostics, Siemens AGand Alere Inc. The comprehensive competitive analysis and profiles of major market players mentioned above are profiled in the report.
KEY BENEFITS FOR STAKEHOLDERS:
This report provides an extensive analysis of the current and emerging trends and dynamics in the world IVD market.
Geographically, the world IVD market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
This report entails the detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists in identifying the prevailing market opportunities.
Exhaustive analysis of the world IVD market by techniques helps in understanding the variants of IVD testing techniques that will gain prominence in the future.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
IVD MARKET KEY SEGMENTS:
By Product type
Software & Services
Other Clinical Techniques
Immune System Disorders
By End Users
Academic & Medical Schools
Following are different modes of Licenses.
a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.
b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.
c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.
1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :
a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]
b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]
2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:
a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.